Pharmacological treatment with thiazolidinediones (TZDs), classical PPARγ full agonists, regulates these PTMs, strongly reverses the unhealthy WAT remodeling, and improves metabolic disorders. The gene discussed is PPARG; the disease is Other metabolic disease.